Reuters logo
BRIEF-European Medicines Agency accepts Basilea's Isavuconazole marketing authorization application for review
August 21, 2014 / 6:10 AM / 3 years ago

BRIEF-European Medicines Agency accepts Basilea's Isavuconazole marketing authorization application for review

Aug 21 (Reuters) - Basilea Pharmaceutica AG : * Says European Medicines Agency accepts Isavuconazole marketing authorization application for review * Seeks approval of Isavuconazole for treatment of invasive aspergillosis and

mucormycosis (zygomycosis) in adults * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below